NPR |
Johnson & Johnson to pay $ 2 billion for false marketing
CNNMoney Johnson & Johnson will pay $ 2.2 billion to settle charges that the company marketed drugs for unapproved uses and paid "kickbacks" to doctors and nursing homes. The penalties announced Monday involve fines and forfeiture to the federal government and … Johnson & Johnson agrees to pay $ 2.2 billion in drug-marketing settlement J&J to pay $ 2.2B for improper promotion of Risperdal J&J to pay $ 2.2B in drug marketing penalties |